Skip to main content
logo
Zenotech Laboratories Limited (BOM:532039)
India flag India · Delayed Price · Currency is INR
44.35
+0.09 (0.20%)
At close: Sep 16, 2026

Zenotech Laboratories Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
405.19401.63390.98368.09390.09329.47
Revenue Growth
4.65%2.72%6.22%-5.64%18.40%69.51%
Gross Profit
405.19366.15347.75337.2360.75298.98
Operating Income
3.527.5673.61102.23141.88109.43
Net Income
-25.17-10.7256.1382.99115.85221.76
Earnings Per Share
-0.42-0.180.921.361.903.63
EPS Growth
---32.36%-28.37%-47.71%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
304.24304.24267.02196.88111.4224.15
Total Debt
-----60
Net Cash (Debt)
304.24304.24267.02196.88111.42-35.85
Net Cash Growth
13.94%13.94%35.63%76.69%--
Net Cash Per Share
5.044.994.383.231.83-0.59

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-102.0595.45118.23206.64176.67
Capital Expenditures
--83.22-39.2-42.34-62.32-19.38
Free Cash Flow
-18.8356.2575.89144.33157.3
Free Cash Flow Growth
--66.53%-25.88%-47.42%-8.25%1796.31%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%91.16%88.94%91.61%92.48%90.75%
Operating Margin
0.86%6.86%18.83%27.77%36.37%33.21%
Pretax Margin
5.70%10.43%27.35%30.27%37.18%30.05%
Profit Margin
-6.21%-2.67%14.36%22.55%29.70%67.31%
FCF Margin
-4.69%14.39%20.62%37.00%47.74%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--56.4543.4724.7913.86
P/FCF Ratio
143.49111.1756.3347.5419.9019.54
PS Ratio
6.675.218.109.807.369.33